Kimberly-Clark Corporation logo

Kimberly-Clark Corporation (KMB)

Market Closed
24 Feb, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
111. 11
+0.6
+0.54%
$
36.19B Market Cap
22.97 P/E Ratio
19.13% Div Yield
3,684,318 Volume
6.59 Eps
$ 110.51
Previous Close
Day Range
109.93 111.41
Year Range
96.26 150.45
Want to track KMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
KMB earnings report is expected in 54 days (20 Apr 2026)
Compared to Estimates, Kimberly-Clark (KMB) Q3 Earnings: A Look at Key Metrics

Compared to Estimates, Kimberly-Clark (KMB) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Kimberly-Clark (KMB) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
Kimberly-Clark (KMB) Q3 Earnings Top Estimates

Kimberly-Clark (KMB) Q3 Earnings Top Estimates

Kimberly-Clark (KMB) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to earnings of $1.74 per share a year ago.

Zacks | 1 year ago
Kimberly-Clark's stock falls after sales fall short, with declines in tissues and personal care

Kimberly-Clark's stock falls after sales fall short, with declines in tissues and personal care

Shares of Kimberly-Clark Corp. fell 3.1% in premarket trading Tuesday, after the parent of consumer brands including Huggies diapers, Kleenex tissues and Scott toilet paper reported third-quarter profit that beat expectations, amid volume and price increases, but sales that fell a bit shy.

Marketwatch | 1 year ago
Kimberly-Clark trims sales forecast as consumers shift to cheaper options

Kimberly-Clark trims sales forecast as consumers shift to cheaper options

Kleenex tissue maker Kimberly-Clark on Tuesday cut its full-year organic net sales forecast after missing Wall Street estimates for third-quarter sales, as cost-conscious consumers swap its pricier personal care goods for cheaper alternatives.

Reuters | 1 year ago
Kimberly-Clark's Q3 Earnings Coming Up: Here's What You Should Know

Kimberly-Clark's Q3 Earnings Coming Up: Here's What You Should Know

KMB's Q3 earnings are likely to reflect the adverse impact of shifting consumer behaviors, retail inventory destocking and rising manufacturing costs.

Zacks | 1 year ago
Kimberly-Clark (KMB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Kimberly-Clark (KMB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Get a deeper insight into the potential performance of Kimberly-Clark (KMB) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 1 year ago
Kimberly-Clark (KMB) Expected to Beat Earnings Estimates: Should You Buy?

Kimberly-Clark (KMB) Expected to Beat Earnings Estimates: Should You Buy?

Kimberly-Clark (KMB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Why Kimberly-Clark (KMB) is Poised to Beat Earnings Estimates Again

Why Kimberly-Clark (KMB) is Poised to Beat Earnings Estimates Again

Kimberly-Clark (KMB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
Are Consumer Staples Stocks Lagging KimberlyClark (KMB) This Year?

Are Consumer Staples Stocks Lagging KimberlyClark (KMB) This Year?

Here is how Kimberly-Clark (KMB) and Vital Farms (VITL) have performed compared to their sector so far this year.

Zacks | 1 year ago
ADRNY or KMB: Which Is the Better Value Stock Right Now?

ADRNY or KMB: Which Is the Better Value Stock Right Now?

Investors interested in Consumer Products - Staples stocks are likely familiar with Ahold NV (ADRNY) and Kimberly-Clark (KMB). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
Kimberly-Clark Stock Trading Above 200 & 50-Day SMA: Should You Buy?

Kimberly-Clark Stock Trading Above 200 & 50-Day SMA: Should You Buy?

KMB is demonstrating strong market resilience and growth with a volume-plus-mix approach, ongoing transformation and investments in innovation and efficiency.

Zacks | 1 year ago
Kimberly-Clark: Good Growth Prospects And An Attractive Dividend Yield

Kimberly-Clark: Good Growth Prospects And An Attractive Dividend Yield

Kimberly-Clark Corporation is poised for growth with volume recovery, innovation, and increased advertising. Margins are expected to improve due to volume leverage, productivity gains, and cost-saving initiatives. The stock is undervalued, trading below historical averages, and offers an attractive forward dividend yield of 3.42%, making it a compelling buy.

Seekingalpha | 1 year ago
Loading...
Load More